These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35018213)

  • 21. A Qualitative Study Exploring Motivators and Barriers to COVID-19 Vaccine Uptake among Adults in South Africa and Zimbabwe.
    Myburgh N; Mulaudzi M; Tshabalala G; Beta N; Gutu K; Vermaak S; Lau C; Hill C; Stanberry L; James W; Madhi S; Makadzange T; Dietrich JJ
    Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-level characteristics of COVID-19 vaccine hesitancy in England: A nationwide cross-sectional study.
    Bucyibaruta G; Blangiardo M; Konstantinoudis G
    Eur J Epidemiol; 2022 Oct; 37(10):1071-1081. PubMed ID: 36121531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 vaccine hesitancy in rural South Africa: Deepening understanding to increase uptake and access.
    Kahn K; Pettifor A; Mataboge P; Kelly NK; Mashinini DP; Nair H; Campbell H; Cohen C; Gómez-Olivé FX; Tollman S
    J Glob Health; 2022 May; 12():05013. PubMed ID: 35567586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of increased mobility on SARS-CoV-2 transmission: a descriptive study of the trends of COVID-19 in Zimbabwe between December 2020 and January 2021.
    Murewanhema G; Burukai TV; Chiwaka L; Maunganidze F; Munodawafa D; Pote W; Mufunda J
    Pan Afr Med J; 2021; 39():125. PubMed ID: 34527141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
    Agosti F; Toffolutti V; Cavalli N; Nivakoski S; Mascherini M; Aassve A
    PLoS One; 2022; 17(9):e0273555. PubMed ID: 36129897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    Sheikh NS; Touseef M; Sultan R; Cheema KH; Cheema SS; Sarwar A; Siddique HZ
    PLoS One; 2023; 18(8):e0289678. PubMed ID: 37585457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.
    Chan NN; Ong KW; Siau CS; Lee KW; Peh SC; Yacob S; Chia YC; Seow VK; Ooi PB
    BMC Public Health; 2022 Feb; 22(1):296. PubMed ID: 35164734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of information sources on COVID-19 vaccine hesitancy and resistance in sub-Saharan Africa.
    Osuagwu UL; Mashige KP; Ovenseri-Ogbomo G; Envuladu EA; Abu EK; Miner CA; Timothy CG; Ekpenyong BN; Langsi R; Amiebenomo OM; Oloruntoba R; Goson PC; Charwe DD; Ishaya T; Agho KE
    BMC Public Health; 2023 Jan; 23(1):38. PubMed ID: 36609264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake.
    Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P
    PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The psychological and behavioural correlates of COVID-19 vaccine hesitancy and resistance in Ireland and the UK.
    Walsh JC; Comar M; Folan J; Williams S; Kola-Palmer S
    Acta Psychol (Amst); 2022 May; 225():103550. PubMed ID: 35259642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccine hesitancy in Africa: a scoping review.
    Ackah BBB; Woo M; Stallwood L; Fazal ZA; Okpani A; Ukah UV; Adu PA
    Glob Health Res Policy; 2022 Jul; 7(1):21. PubMed ID: 35850783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing parents' hesitancy to vaccinate their children aged 5-11 years old against COVID-19: results from a cross-sectional study in Malaysia.
    Marzo RR; Chakraborty R; Soh SY; Thew HZ; Chong C; Siau CS; Abdul Wahab KB; Binti Ariffin IA; Chauhan S; Brackstone K; Padhi BK; Heidler P
    Front Public Health; 2023; 11():1091015. PubMed ID: 37261237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.
    Reid JA; Mabhala MA
    Isr J Health Policy Res; 2021 May; 10(1):33. PubMed ID: 34044891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Vaccine Hesitancy and Acceptance Among Individuals With Cancer, Autoimmune Diseases, or Other Serious Comorbid Conditions: Cross-sectional, Internet-Based Survey.
    Tsai R; Hervey J; Hoffman K; Wood J; Johnson J; Deighton D; Clermont D; Loew B; Goldberg SL
    JMIR Public Health Surveill; 2022 Jan; 8(1):e29872. PubMed ID: 34709184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first year of COVID-19 vaccine roll-out in Africa: challenges and lessons learned.
    Masresha B; Ruiz MAS; Atuhebwe P; Mihigo R
    Pan Afr Med J; 2022; 41(Suppl 2):2. PubMed ID: 36159028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey.
    Zheng W; Sun Y; Li H; Zhao H; Zhan Y; Gao Y; Hu Y; Li P; Lin YF; Chen H; Meng H; Yang C; Fang Q; Yuan J; Jiang Y; Liu S; Cai Y; Zou H
    Hum Vaccin Immunother; 2021 Dec; 17(12):4971-4981. PubMed ID: 34890297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
    Afreh OK; Angwaawie P; Attivor E; Boateng LA; Brackstone K; Head MG; Manyeh AK; Vidzro G
    Vaccine; 2023 Mar; 41(13):2113-2119. PubMed ID: 36822965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study.
    Takoudjou Dzomo GR; Mbario E; Djarma O; Soumbatingar N; Madengar M; Djimera N; Djindimadje A; Nguemadjita C; Nassaringar G; Bernales M; Nangerngar T; Naissem D; Paningar E; Gomez-Virseda C; Lopez Barreda R; Robbins I; Cournil A; Visier L; Tuaillon E; Mennechet FJD
    Front Public Health; 2022; 10():1063954. PubMed ID: 36684864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
    Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
    Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.